What is the price target for CROX stock?
23 analysts have analysed CROX and the average price target is 104.82 USD. This implies a price increase of 2.82% is expected in the next year compared to the current price of 101.95.
NASDAQ:CROX • US2270461096
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for CROCS INC (CROX).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-03-10 | BTIG | Initiate | Neutral |
| 2026-02-13 | Stifel | Maintains | Hold -> Hold |
| 2026-02-13 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2026-02-13 | Goldman Sachs | Maintains | Sell -> Sell |
| 2026-02-12 | Needham | Maintains | Buy -> Buy |
| 2026-01-22 | Keybanc | Downgrade | Overweight -> Sector Weight |
| 2026-01-08 | BWG Global | Upgrade | Negative -> Mixed |
| 2026-01-07 | Baird | Downgrade | Outperform -> Neutral |
| 2025-12-05 | Needham | Reiterate | Buy -> Buy |
| 2025-10-31 | Stifel | Maintains | Hold -> Hold |
| 2025-10-31 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2025-10-21 | B of A Securities | Maintains | Buy -> Buy |
| 2025-09-22 | Piper Sandler | Downgrade | Overweight -> Neutral |
| 2025-08-29 | Needham | Maintains | Buy -> Buy |
| 2025-08-11 | UBS | Maintains | Neutral -> Neutral |
| 2025-08-08 | Keybanc | Maintains | Overweight -> Overweight |
| 2025-08-08 | Stifel | Downgrade | Buy -> Hold |
| 2025-08-08 | Barclays | Downgrade | Overweight -> Equal-Weight |
| 2025-08-08 | B of A Securities | Maintains | Buy -> Buy |
| 2025-08-07 | Needham | Maintains | Buy -> Buy |
| 2025-07-28 | UBS | Maintains | Neutral -> Neutral |
| 2025-07-22 | Goldman Sachs | Maintains | Sell -> Sell |
| 2025-07-02 | Goldman Sachs | Initiate | Sell |
| 2025-06-30 | B of A Securities | Maintains | Buy -> Buy |
| 2025-05-09 | Barclays | Maintains | Overweight -> Overweight |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | ||
|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 3.962B 11.46% | 4.102B 3.53% | 4.041B -1.50% | 4.117B 1.89% | 4.219B 2.48% | 4.212B -0.17% | 4.654B 10.49% | |
| EBITDA YoY % growth | 1.101B 20.34% | 1.117B 1.46% | 968.012M -13.33% | 999.33M 3.24% | 1.015B 1.57% | 971.14M -4.32% | 1.25B 28.71% | |
| EBIT YoY % growth | 1.046B 19.53% | 1.047B 0.05% | 888.73M -15.12% | 918.02M 3.30% | 946.5M 3.10% | 899.09M -5.01% | 1.15B 27.91% | |
| Operating Margin | 26.41% | 25.52% | 21.99% | 22.30% | 22.43% | 21.35% | 24.71% | |
| EPS YoY % growth | 12.03 10.27% | 13.15 9.31% | 12.44 -5.40% | 13.57 9.08% | 14.46 6.59% | 14.55 0.59% | 15.13 3.97% |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | Q1 / 28 | Q2 / 28 | Q3 / 28 | Q4 / 28 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 2.81 -6.17% | 4.39 3.71% | 3.53 20.92% | 2.79 22.00% | 3.07 9.05% | 4.77 8.84% | 3.79 7.33% | 2.96 5.97% | 2.90 -5.63% | 4.92 2.97% | 3.53 -6.88% | 2.18 -26.27% |
| Revenue Q2Q % growth | 917.29M -2.14% | 1.149B -0.03% | 1.044B 4.79% | 1.007B 5.15% | 984.12M 7.29% | 1.177B 2.44% | 1.067B 2.20% | 1.052B 4.47% | 914.94M -7.03% | 1.175B -0.17% | 1.039B -2.62% | N/A |
| EBITDA Q2Q % growth | 215.03M -10.96% | 311.78M -10.56% | 256.27M -3.66% | 211.87M -6.12% | 223.95M 4.15% | 333.25M 6.89% | 267.61M 4.43% | 220.69M 4.16% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | 197.03M -11.64% | 292.5M -5.83% | 238.33M 14.77% | 193.23M 31.99% | 210.49M 6.83% | 316.24M 8.12% | 248.39M 4.22% | 199.23M 3.11% | N/A | N/A | N/A | N/A |
All data in USD
23 analysts have analysed CROX and the average price target is 104.82 USD. This implies a price increase of 2.82% is expected in the next year compared to the current price of 101.95.
CROCS INC (CROX) will report earnings on 2026-05-06, before the market open.
The consensus EPS estimate for the next earnings of CROCS INC (CROX) is 2.81 USD and the consensus revenue estimate is 917.29M USD.
The number of analysts covering CROCS INC (CROX) is 23.